Nektar Therapeutics NKTR
NASDAQ NKTR
$59.29 -1.11 (-1.84%)
As of: Sep 29, 2026 · 3:59 PM EDT

Nektar Therapeutics (NKTR) Current Assets (2010 - 2026)

Updated

Nektar Therapeutics' Current Assets came in at $739.4 million for Q2 2026, up 296.3% from $186.57 million a year earlier and up 25.5% from the prior quarter.

Analysis

Nektar Therapeutics (NKTR) Current Assets (2010 - 2026) Analysis & Trends

At the end of FY2025, Nektar Therapeutics' Current Assets was $266.27 million, up 1.9% from FY2024.

  • Current Assets carries a five-year compound annual growth rate of -25.2% (FY2020 to FY2025).
  • Going back by year, Current Assets was $261.29 million in FY2024 (-21.0%), $330.7 million in FY2023 (-39.4%), $545.97 million in FY2022 (-31.4%) and $795.58 million in FY2021 (-30.1%).
  • The Q2 2026 figure represents the highest quarterly Current Assets since Q4 2021.
  • Year-over-year, Current Assets has increased for three consecutive quarters, with growth averaging 42.3% over the last eight quarters.
  • The fastest year-over-year change in Current Assets over five years came in Q2 2026 (growth of 296.3%), and the weakest in Q4 2023 (a decline of 39.4%).
  • Business Quant data shows NKTR's Current Assets at $589.04 million (Q1 2026), $266.27 million (Q4 2025) and $281.36 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Nektar Therapeutics 2.00 Bn 227.61 Mn - 739.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 739.40 Mn
Mar 31, 2026 589.04 Mn
Dec 31, 2025 266.27 Mn
Sep 30, 2025 281.36 Mn
Jun 30, 2025 186.57 Mn
Mar 31, 2025 229.91 Mn
Dec 31, 2024 261.29 Mn
Sep 30, 2024 286.48 Mn
Jun 30, 2024 295.19 Mn
Mar 31, 2024 319.84 Mn
Dec 31, 2023 330.70 Mn
Sep 30, 2023 399.03 Mn
Jun 30, 2023 441.06 Mn
Mar 31, 2023 491.07 Mn
Dec 31, 2022 545.97 Mn
Sep 30, 2022 599.48 Mn
Jun 30, 2022 665.54 Mn
Mar 31, 2022 733.46 Mn
Dec 31, 2021 795.58 Mn
Sep 30, 2021 986.14 Mn
API Access

Nektar Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=NKTR&period=max&api_key=YOUR_API_KEY